Mise à jour d'une déclaration précédente
No de la demande: 2013-6359
Numéro de référence du titulaire d'homologation: PROSAR case #: 1-35273806
Nom du titulaire (nom légal complet, aucune abbréviation): The Hartz Mountain Corporation
Adresse: 400 Plaza Drive
Ville: Secaucus
État: New Jersey
Pays: USA
Code postal /Zip: 07094-3688
Incident chez un animal domestique
Pays: UNITED STATES
État: TENNESSEE
ARLA No d'homologation ARLA No de la demande d'homologation EPA No d'homologation. 2596-167
Nom du produit: Ultraguard Flea/Tick Prevention for Dogs/Puppies 15-30 lbs.
Liquide
Oui
Inconnu
Site: Animal / Usage sur un animal domestique
Inconnu
Propriétaire de l'animal
Dog / Chien
Mixed Breed
1
Inconnu
1
25
lbs
Cutanée
Unknown / Inconnu
>8 hrs <=24 hrs / > 8 h < = 24 h
Système
Persisted until death
Non
Non
Mort
Treatment / Traitement
(p.ex. description des symptômes tels que la fréquence et la gravité
1-35273806 -The reporter, a pet owner, indicated that his dog was exposed to a spot-on product containing the active ingredients etofenprox, n-octyl bicycloheptene dicarboximide and piperonyl butoxide. The reporter applied the product to his 1-year-old, 25 pound, male neutered mixed breed dog one day prior to initial contact with the registrant in the morning and that evening, when the reporter got home from work, he noted that his dog was drowsy. The next morning the dog was found dead. The body was submitted for necropsy to the (name) Veterinary Diagnostic Laboratory. Necropsy revealed a large amount of unclotted blood (estimated to be about 1 liter) in the thoracic cavity. The pathologist indicated that the cause of death was almost certainly intrathoracic hemorrhage. Which per the pathologist may have been secondary to thymic regression leading to either spontaneous bleeding or bleeding secondary to minor trauma and/or spontaneous bleeding secondary to anticoagulant rodenticide ingestion. The pathologist indicated that the fact that the blood was unclotted was supportive of an anticoagulant rodenticide ingestion. Initial brain cholinesterase testing showed 80% suppression of cholinesterase activities which per the pathology laboratory was indicative of poisoning with either an organophosphate or a carbamate. On follow-up call, to the (name) pathology laboratory, the pathologist (Dr. name) indicated that the two findings were unrelated to each other and they planned on re-running the cholinesterase test while using a control to check for lab error. The results of this repeated cholinesterase test are not yet available. During the follow-up call the pathologist also indicated that pyrethroid hair testing did confirm an exposure to etofenprox. Which per the pathologist provided confirmation that the dog had been exposed to etofenprox but did not confirm that the dogs symptoms or its death were secondary to exposure to the etofenprox. No further information is available.
Mort
Status update: 1-35273806 - A Second brain cholinesterase analysis using a fresh internal normal was run and results were 33% of normal. Exposure to a cholinesterase-inhibiting compound can be determined if the cholinesterase activity in brain tissues is less than 25% of normal. Therefore, since the results of the second cholinesterase test were greater than 25% of normal there is no evidence that this dog was exposed to a cholinesterase inhibiting compound.